EN DE

Beijing Labtech Instruments Co (688056) Fair Value & Analysis

Technology · CN · Market cap 4.1B CNY

BL Beijing Labtech Instruments Co 688056 · SHG
Price¥44.10
Fair Value¥11.68
Upside-73.5%
Quality69/100
Watch Beijing Labtech Instruments Co for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 8.8% net margin
generates free cash flow
Trails peers (2/12)
Narrow moat 35/100
Evidence: High Range ¥8.76 – ¥14.60 Share as image

Fair value as of: Jul 12, 2026

From 25 valuation models · updated 29 days ago

Fair value updated Jul 12, 2026, revised from ¥13.04 to ¥11.68 (−10.4%) since Jun 24, 2026. Share price −11.4% over the past month.

A solid business, but screening 74% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥14.60). The favourable scenario is already priced in.
  • Solid but not exceptional quality (69/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥77.79 ¥17.42 Fair Value ¥11.68 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.

How to read this chart

60‑month range ¥17.42 – ¥77.79 · fair‑value band ¥8.76 – ¥14.60 · the ¥44.10 price screens above the ¥11.68 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Beijing Labtech Instruments Co (688056) currently trades at ¥44.10, while our model-based Fair Value estimate is ¥11.68, implying the stock looks roughly 73.5% overvalued today. The Quality Score stands at 69/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Beijing Labtech Instruments Co generated revenue of 389M CNY at a net margin of 8.8%. Revenue declined 12.4% year over year. It earns a return on equity of 4.2%. The balance sheet holds a net cash position of 287M CNY. Fundamentals as of Jul 12, 2026

Our scenario range runs from ¥8.76 (bear case) to ¥14.60 (bull case); at ¥44.10, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 43% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at -45% fair-value upside, at -74%, 688056 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income ¥9.14 ¥9.29 ¥8.80 76
Growth DCF ¥8.97 ¥10.80 ¥13.16 72
Gordon GGM ¥5.22 ¥8.10 ¥11.17 70
All 25 models by family
DCF Models
FCF DCF ¥8.83 ¥10.79 ¥13.44 38
Owner Earnings ¥11.40 ¥14.38 ¥18.39 31
5Y Revenue Exit ¥9.33 ¥12.20 ¥15.71 39
5Y EBITDA Exit ¥10.58 ¥14.39 ¥18.62 41
5Y P/E Exit ¥10.50 ¥14.26 ¥17.97 38
10Y Revenue Exit ¥8.92 ¥11.40 ¥14.42 36
10Y EBITDA Exit ¥9.85 ¥12.84 ¥16.47 37
10Y P/E Exit ¥9.80 ¥12.75 ¥16.01 35
Earnings-Based
Graham-Dodd ¥3.97 ¥8.76 ¥11.17 54
PEG = 1.0 ¥1.40 ¥2.00 ¥2.60 46
EPV ¥9.22 ¥10.06 ¥10.79 59
Dividend Discount
Gordon GGM ¥5.22 ¥8.10 ¥11.17 70
DDM Multi-Stage ¥5.22 ¥7.44 ¥9.85 61
Multiples
P/E Multiple ¥8.76 ¥11.68 ¥14.60 63
P/S Multiple ¥7.44 ¥9.92 ¥12.41 58
P/B Multiple ¥7.44 ¥9.92 ¥12.41 55
EV/EBIT ¥13.01 ¥16.06 ¥19.10 53
EV/EBITDA ¥12.78 ¥15.74 ¥18.71 54
EV/Revenue ¥10.04 ¥12.67 ¥15.31 43
Asset-Based
NCAV (Graham) ¥6.01 ¥8.05 ¥12.01 50
Growth DCF
Growth DCF ¥8.97 ¥10.80 ¥13.16 72
Rev-Margin DCF ¥9.33 ¥12.25 ¥15.33 67
Economic Profit
Residual Income ¥9.14 ¥9.29 ¥8.80 76
ROIC Compounder ¥9.22 ¥10.06 ¥10.79 67
Growth Earnings
Growth-Adj P/E ¥6.53 ¥9.33 ¥12.13 68

Widest divergence: DCF Models (¥12.75) versus Dividend Discount (¥7.44). Highest evidence: Residual Income (76).

Key figures & financial health

Revenue (TTM) 389M CNY
Revenue growth (YoY) -12.4%
Net margin 8.8%
Return on equity 4.2%
Free cash flow 33.3M CNY FY2025
P/E ratio 118.2
More key figures
Operating margin 5.7%
EPS (TTM) ¥0.5100
EPS growth (YoY) -47.4%
Net cash 287M CNY FY2024

Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 69/100

Of which business quality 68 · Market factors (momentum, volatility) 67

Profitability 43
Margins and returns on capital today
Quality Growth 51
Are margins and returns improving?
Cashflow 51
Earnings quality: real cash, not paper profit
Fin. Strength 99
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 83
Price trend over the last 3–12 months (market factor)
52W Momentum 58
Distance to the 52-week high (market factor)
Net Issuance 78
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Beijing Labtech Instruments Co., Ltd. manufactures and supplies laboratorial products and solutions to laboratory industry worldwide.

Full company description

Beijing Labtech Instruments Co., Ltd. manufactures and supplies laboratorial products and solutions to laboratory industry worldwide. It offers water chillers, rotary evaporators, digestion blocks, vacuum pumps, and hot plates; AutoClean GPC cleanup, SepLine solid phase extraction, Sepath solid phase extraction, concentration systems, digestion systems, and evaporation systems; and analytical instruments, including gradient and isocratic HPLC, and UV-Vis spectrophotometers. The company was founded in 2002 and is headquartered in Beijing, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Beijing Labtech Instruments Co reported revenue of ¥402M in FY2025 versus ¥369M in FY2021, a compound +2.2%/yr. Reported net income was ¥39.4M in FY2025, compounding −13.2%/yr from FY2021.

Growth Quality 50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
402M CNY
Latest YoY
−5.1%
Avg. growth/yr (3Y)
+4.3%
Avg. growth/yr (5Y)
+2.9%
Avg. growth/yr (13Y)
+6.0%
Revenue +2.2%/yr
FY21 ¥369M
FY22 ¥355M
FY23 ¥416M
FY24 ¥424M
FY25 ¥402M
Net income −13.2%/yr
FY21 ¥69.4M
FY22 ¥44.6M
FY23 ¥27.6M
FY24 ¥39.1M
FY25 ¥39.4M

688056 screens 74% overvalued. Compare with Keysight Technologies, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Beijing Labtech Instruments Co Fair Value". https://www.fairvalue-calculator.com/stock/688056

Peer Group

Scientific & Technical Instruments · 161 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 69 · Top 25%
Fair Value upside −74% · Bottom 25%
Return on equity (TTM) 4% · Below median
Return on assets 2% · Below median
Net margin (TTM) 9% · Above median
Operating margin (TTM) 6% · Below median
Revenue growth -12% · Bottom 25%

Valuation Multiples vs Scientific & Technical Instruments median · lower = cheaper

P/E (TTM) 118.2× · Pricier than 75% of peers
P/B 5.02× · Pricier than 75% of peers
P/S (TTM) 10.46× · Pricier than 75% of peers
P/FCF 18.1× · Pricier than median
EV/EBITDA 86.7× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 34
PAST 17 · sector 25
HEALTH 0 · sector 98
DIVIDEND 0 · sector 24

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).

Stock Price Fair Value vs Fair Value
Keysight Technologies, Inc KEYS $315.90 $84.16 -73%
Garmin Ltd GRMN $241.76 $146.67 -39%
Teledyne Technologies Incorporated TDY $635.52 $367.58 -42%
Chroma ATE Inc 2360 1,905 TWD 286.15 TWD -85%
Hexagon AB HEXAB kr 80.10 kr 52.93 -34%
MKS Inc MKSI $324.69 $77.46 -76%
AVIC Chengdu Aircraft Company 302132 ¥52.91 ¥34.47 -35%
Fortive Corporation FTV $61.78 $33.84 -45%
Trimble Inc TRMB $52.72 $24.47 -54%
Cognex Corporation CGNX $64.07 $13.75 -79%

Compare Beijing Labtech Instruments Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Beijing Labtech Instruments Co (688056) overvalued or undervalued?
As of Jul 12, 2026, our model estimates a fair value of ¥11.68 versus a price of ¥44.10, about −74% (overvalued).
What is the fair value of 688056?
Our model-based fair value for Beijing Labtech Instruments Co is ¥11.68 (as of Jul 12, 2026), built from audited fundamentals. The current price is ¥44.10.
What is the quality score of 688056?
Beijing Labtech Instruments Co has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Beijing Labtech Instruments Co (688056)?
Beijing Labtech Instruments Co reported trailing-twelve-month revenue of about 389M CNY (latest available figure, as of Jul 12, 2026).
What is the net profit margin of 688056?
The net profit margin of Beijing Labtech Instruments Co is about 8.8%, meaning it keeps roughly 8.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Beijing Labtech Instruments Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.